Detalhe da pesquisa
1.
Alternative State-Level Financing for Hepatitis C Treatment-The "Netflix Model".
JAMA
; 320(19): 1977-1978, 2018 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30383176
2.
Value-based performance arrangements for chronic conditions: an economic simulation of Medicaid Drug Rebate Program reforms.
Expert Rev Pharmacoecon Outcomes Res
; 23(5): 535-546, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36987666
3.
Durable cell and gene therapy potential patient and financial impact: US projections of product approvals, patients treated, and product revenues.
Drug Discov Today
; 27(1): 17-30, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34537333
4.
Biosimilars And Follow-On Products In The United States: Adoption, Prices, And Users.
Health Aff (Millwood)
; 40(6): 989-999, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34097520
5.
Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers.
Nat Rev Drug Discov
; 6(4): 287-93, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17380152
6.
Personalized medicine and health economics: is small the new big? A white paper.
Isr Med Assoc J
; 15(10): 602-7, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24266085
7.
Biosimilars And Follow-On Products: The Authors Reply.
Health Aff (Millwood)
; 40(9): 1516, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34495725
8.
The clinical benefits, ethics, and economics of stratified medicine and companion diagnostics.
Drug Discov Today
; 20(12): 1439-50, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26542060
9.
Comparison of Stakeholder Metrics for Traditional and Adaptive Development and Licensing Approaches to Drug Development.
Ther Innov Regul Sci
; 47(4): 474-483, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30235525
10.
Uncertain prognosis for high-quality diagnostics: clinical challenges, economic barriers and needed reforms.
Pharmacogenomics
; 14(3): 325-34, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23394394
11.
Economic challenges and possible policy actions to advance stratified medicine.
Per Med
; 9(4): 413-427, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29776261
12.
Quantifying factors for the success of stratified medicine.
Nat Rev Drug Discov
; 10(11): 817-33, 2011 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-22037040
13.
Market watch: defining and quantifying the use of personalized medicines.
Nat Rev Drug Discov
; 12(12): 896-7, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24287770